Number 1 open access journal in Endocrinology & Metabolism
We are delighted to let you know that Cardiovascular Diabetology achieved the highest Impact Factor in its history! The journal’s Impact Factor is now 5.235 and it is the number 1 most cited open access journal worldwide within the category “Endocrinology & metabolism”. The journal is also ranked in the top quartile in the category “Cardiac & cardiovascular systems”. These achievements represent a continuous and unbroken yearly IF growth since 2013.
Read our guide to journal metrics here!
Aims and scope
"Since the American Heart Association stated in 1999 that "diabetes is a cardiovascular disease", many revolutionary events took place in the rapidly evolving field of cardiovascular diabetology. The initial 'bridal' between heart diseases and diabetes is at present a vast and complex interdisciplinary texture which includes innovative biotechnological approaches, such as genomics, proteomics, metabolomics, molecular biometrics, bioinformatics, customized therapies and various additional sophisticated practices. Our journal endeavors to be a harbinger of these fascinating advances."
Professor Enrique Fisman, Editor-in-Chief, Cardiovascular Diabetology
"A strong correlation between cardiovascular disease and diabetes is now well established. The American Heart Association considers that individuals with insulin resistance or diabetes are more likely to fall victim to heart disease or stroke. Cardiovascular Diabetology is the world's foremost journal specifically devoted to this issue. Submitted manuscripts may report any aspect of laboratory, animal, or human research related to diabetes and its cardiovascular complications"
Professor Alexander Tenenbaum, Editor-in-Chief, Cardiovascular Diabetology
2017 Journal Metrics
28.1 days from submission to first decision
71.3 days from submission to acceptance
12.7 days from acceptance to publication
706 Altmetric mentions